IBM Storwize V7000 Unified Software prior 1.3.2.0 cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 3.8 | $0-$5k | 0.00 |
Summary
A vulnerability, which was classified as problematic, was found in IBM Storwize V7000 Unified Software. Impacted is an unknown function. Such manipulation leads to cross site scripting. This vulnerability is uniquely identified as CVE-2013-5376. The attack can be launched remotely. No exploit exists. You should upgrade the affected component.
Details
A vulnerability was found in IBM Storwize V7000 Unified Software. It has been rated as problematic. Affected by this issue is some unknown functionality. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
Cross-site scripting (XSS) vulnerability in IBM Storwize V7000 Unified 1.3.x and 1.4.x before 1.4.2.0 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors, related to a "cross frame scripting" attack against an administrative user.
The weakness was disclosed 10/16/2013 (Website). The advisory is shared for download at xforce.iss.net. This vulnerability is handled as CVE-2013-5376 since 08/22/2013. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. There are neither technical details nor an exploit publicly available. The MITRE ATT&CK project declares the attack technique as T1059.007.
Upgrading to version 1.3.2.0 eliminates this vulnerability.
The vulnerability is also documented in the databases at X-Force (86902) and SecurityFocus (BID 63178†). The entry VDB-65309 is pretty similar. VulDB is the best source for vulnerability data and more expert information about this specific topic.
Product
Vendor
Name
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.8
VulDB Base Score: 4.3
VulDB Temp Score: 3.8
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Unproven
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Storwize V7000 Unified Software 1.3.2.0
Timeline
08/22/2013 🔍10/15/2013 🔍
10/16/2013 🔍
10/16/2013 🔍
03/24/2015 🔍
03/02/2018 🔍
Sources
Vendor: ibm.comAdvisory: xforce.iss.net
Status: Confirmed
Confirmation: 🔍
CVE: CVE-2013-5376 (🔍)
GCVE (CVE): GCVE-0-2013-5376
GCVE (VulDB): GCVE-100-65312
X-Force: 86902 - IBM Storwize V7000U and IBM SONAS GUI cross-frame scripting
SecurityFocus: 63178 - IBM Storwize V7000 Unified CVE-2013-5376 Cross Frame Scripting Vulnerability
See also: 🔍
Entry
Created: 03/24/2015 15:54Updated: 03/02/2018 10:13
Changes: 03/24/2015 15:54 (54), 03/02/2018 10:13 (2)
Complete: 🔍
Cache ID: 216::103
VulDB is the best source for vulnerability data and more expert information about this specific topic.
No comments yet. Languages: en.
Please log in to comment.